{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:12Z","timestamp":1740144192167,"version":"3.37.3"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["2016-ER6304-02"],"award-info":[{"award-number":["2016-ER6304-02"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>This study investigated the impacts of renin\u2013angiotensin system inhibitors (RASIs) on 2-year clinical outcomes in diabetes and dyslipidemic acute myocardial infarction (AMI) patients after a successful percutaneous coronary intervention (PCI) using newer-generation drug-eluting stents (DESs).<\/jats:p>\n            <jats:p>A total of 16,997 AMI patients were enrolled, and divided into four groups based on the presence or absence of diabetes and dyslipidemia as follows: diabetes \u2013\/dyslipidemia \u2013(group A, 11,132 patients), diabetes +\/dyslipidemia \u2013 (group B, 3,860 patients), diabetes \u2013\/dyslipidemia + (group\u200aC, 1,328 patients), and diabetes +\/dyslipidemia + (group D, 677 patients). The clinical endpoint was the occurrence of major adverse cardiac events (MACEs), the composite of total death, recurrent myocardial infarction (re-MI), and any repeat revascularization, including target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target vessel revascularization (non-TVR).<\/jats:p>\n            <jats:p>After RASIs therapy, the cumulative incidences of MACEs (adjusted hazard ratio [aHR], 1.330; 95% confidence interval [CI], 1.022\u20131.732; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.034), any repeat revascularization (aHR, 1.584; 95% CI, 1.092\u20132.298; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.015), TLR, and TVR were significantly higher in group B than group C. However, the cumulative incidences of all-cause death, cardiac death, re-MI, and non-TVR were similar in groups B and C.<\/jats:p>\n            <jats:p>In this study, under the newer-generation DESs era, repeat revascularization rate reduction benefit of RASIs therapy in diabetic AMI patients was lesser than that in dyslipidemic AMI patients. However, larger randomized controlled studies are needed to confirm these results in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021289","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T23:06:01Z","timestamp":1595372761000},"page":"e21289","source":"Crossref","is-referenced-by-count":0,"title":["Impacts of renin\u2013angiotensin system inhibitors on two-year clinical outcomes in diabetic and dyslipidemic acute myocardial infarction patients after a successful percutaneous coronary intervention using newer-generation drug-eluting stents"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9669-3598","authenticated-orcid":false,"given":"Yong Hoon","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ae-Young","family":"Her","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Department of Cardiology, Chonnam National University Hospital, Gwangju"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Jin","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seunghwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Min","family":"Ahn","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Guk","family":"Ko","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong-Ki","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangsoo","family":"Jang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014\u200aAHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"R6-20230915","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1016\/j.amjhyper.2004.08.004","article-title":"The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications","volume":"17","author":"Cooper","year":"2004","journal-title":"Am J Hypertens"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjhyper.2004.07.001","article-title":"Of the renin-angiotensin system and reactive oxygen species type 2 diabetes and angiotensin II inhibition","volume":"18","author":"Leiter","year":"2005","journal-title":"Am J Hypertens"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1262-3636(07)70147-7","article-title":"Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms","volume":"30","author":"Scheen","year":"2014","journal-title":"Diabetes Metab"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.amjcard.2009.05.015","article-title":"Role of renin-angiotensin system blockade in patients with diabetes mellitus","volume":"104","author":"Braga","year":"2009","journal-title":"Am J Cardiol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"e1001971","DOI":"10.1371\/journal.pmed.1001971","article-title":"Cardiovascular and renal outcomes of renin-angiotensin system blockade in adult patients with diabetes mellitus: a systematic review with network meta-analyses","volume":"13","author":"Catal\u00e1-L\u00f3pez","year":"2016","journal-title":"PLoS Med"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/endo.135.5.7956925","article-title":"Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II","volume":"135","author":"Darimont","year":"1994","journal-title":"Endocrinology"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1210\/endo.138.4.5038","article-title":"Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells","volume":"138","author":"Jones","year":"1997","journal-title":"Endocrinology"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.numecd.2016.07.013","article-title":"Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia","volume":"27","author":"Borghi","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.CIR.100.21.2131","article-title":"Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men","volume":"100","author":"Nickenig","year":"1999","journal-title":"Circulation"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/07853890008995944","article-title":"Angiotensin AT1 receptor over-expression in hypercholesterolaemia","volume":"32","author":"Strehlow","year":"2000","journal-title":"Ann Med"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2018.381","article-title":"Current status of acute myocardial infarction in Korea","volume":"34","author":"Kim","year":"2019","journal-title":"Korean J Intern Med"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/bmj.326.7399.1137","article-title":"ABC of interventional cardiology: percutaneous coronary intervention. II: the procedure","volume":"326","author":"Grech","year":"2003","journal-title":"BMJ"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/ccd.27985","article-title":"Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: data from the Korea Acute Myocardial Infarction Registry","volume":"93","author":"Kim","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.repc.2014.08.020","article-title":"Prevalence of dyslipidemia in adolescents: comparison between definitions","volume":"34","author":"Tomeleri","year":"2015","journal-title":"Rev Port Cardiol"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.106.620864","article-title":"Distribution of lipoproteins by age and gender in adolescents","volume":"114","author":"Jolliffe","year":"2006","journal-title":"Circulation"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5551\/jat.15792","article-title":"Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan\u20142012 version","volume":"20","author":"Teramoto","year":"2013","journal-title":"Atheroscler Thromb"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/dc18-1307","article-title":"A comparison of the 2017 American College of Cardiology\/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes","volume":"41","author":"Muntner","year":"2018","journal-title":"Diabetes Care"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1253\/circj.71.524","article-title":"Role of activated renin-angiotensin system in myocardial fibrosis and left ventricular diastolic dysfunction in diabetic patients\u2014reversal by chronic angiotensin II type 1A receptor blockade","volume":"71","author":"Kawasaki","year":"2007","journal-title":"Circ J"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jcmg.2018.08.024","article-title":"Changes in coronary plaque composition in patients with acute myocardial infarction treated with high-intensity statin therapy (IBIS-4): a serial optical coherence tomography study","volume":"12","author":"R\u00e4ber","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1097\/MJT.0000000000000370","article-title":"Effects of first high-dose atorvastatin loading in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention","volume":"25","author":"Li","year":"2018","journal-title":"Am J Ther"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N Engl J Med"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1472-8206.2009.00704.x","article-title":"Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial","volume":"23","author":"Borghi","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2018.11.030","article-title":"Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: comparison between STEMI and NSTEMI","volume":"280","author":"Kim","year":"2019","journal-title":"Atherosclerosis"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.jacc.2014.01.064","article-title":"Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials","volume":"63","author":"Kedhi","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.10.014","article-title":"Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial","volume":"55","author":"Kapur","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.amjcard.2010.12.013","article-title":"Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry","volume":"107","author":"Tada","year":"2011","journal-title":"Am J Cardiol"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacc.2007.10.035","article-title":"Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials","volume":"51","author":"Kirtane","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ccd.28194","article-title":"Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial","volume":"94","author":"Jimenez-Quevedo","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R37-20230915","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/157016106777698397","article-title":"The molecular mechanisms of vascular restenosis: which genes are crucial?","volume":"4","author":"Bhoday","year":"2006","journal-title":"Curr Vasc Pharmacol"},{"key":"R38-20230915","first-page":"9","article-title":"In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation","volume":"67","author":"Mizia-Stec","year":"2009","journal-title":"Kardiol Pol"},{"key":"R39-20230915","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/ATVBAHA.109.190215","article-title":"How we learned to say NO","volume":"29","author":"Vanhoutte","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R40-20230915","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2174\/1381612824666180702154129","article-title":"Dyslipidemias and microcirculation","volume":"24","author":"Padr\u00f3","year":"2018","journal-title":"Curr Pharm Des"},{"key":"R41-20230915","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jbm.b.30974","article-title":"Approaches for prevention of restenosis","volume":"85","author":"Kraitzer","year":"2008","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"R42-20230915","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa0810116","article-title":"Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction","volume":"360","author":"Stone","year":"2009","journal-title":"N Engl J Med"},{"key":"R43-20230915","first-page":"S50","article-title":"Prehypertension and cardiovascular risk factors in children and adolescents participating in the community-based prevention education program family heart study","volume":"5","author":"Haas","year":"2014","journal-title":"Int J Prev Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:00:31Z","timestamp":1694826031000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":43,"journal-issue":{"issue":"30","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021289","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,7,24]]}}}